EJMK Ventures’s Bristol-Myers Squibb BMY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$217K Buy
+3,473
New +$219K 0.09% 157
2026
Q2
– Sell
-3,619
Closed -$219K – 165
2026
Q1
$219K Sell
3,619
-993
-22% -$57.9K 0.12% 155
2025
Q4
$249K Buy
+4,612
New +$222K 0.15% 153

Other funds holding BMY

EJMK Ventures's BMY Position: Q3 2026 in Review

EJMK Ventures opened a new position in Bristol-Myers Squibb (BMY) in Q3 2026: 3,473 shares worth $217K. The stake represents 0.09% of the portfolio and ranks #157 among its holdings. This is a return to the name: EJMK Ventures previously reported a position in BMY as recently as Q1 2026.

EJMK Ventures first reported a position in BMY in Q4 2025 and has held it in 3 quarters since. The position peaked at $249K in Q4 2025. 2,561 funds tracked by Wall St. Rank hold BMY as of Q3 2026.

  • EJMK Ventures held 3,473 shares of Bristol-Myers Squibb worth $217K as of Q3 2026.
  • Bristol-Myers Squibb was a new EJMK Ventures position in Q3 2026.
  • Bristol-Myers Squibb made up 0.09% of EJMK Ventures's portfolio in Q3 2026, its #157 holding.
  • EJMK Ventures first reported a position in Bristol-Myers Squibb in Q4 2025 and has held it in 3 quarters since.
  • EJMK Ventures's Bristol-Myers Squibb position peaked at $249K in Q4 2025.
  • 2,561 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q3 2026.

Based on EJMK Ventures's 13F filing for Q3 2026, filed 21 Oct 2026.